Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
about
Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancerNear-infrared light modulated photothermal effect increases vascular perfusion and enhances polymeric drug delivery.Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mappingMicelles based on biodegradable poly(L-glutamic acid)-b-polylactide with paramagnetic Gd ions chelated to the shell layer as a potential nanoscale MRI-visible delivery system.Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent.Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813.Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model.On the use of molecular weight cutoff cassettes to measure dynamic relaxivity of novel gadolinium contrast agents: example using hyaluronic Acid polymer complexes in phosphate-buffered salineThe degradation and clearance of Poly(N-hydroxypropyl-L-glutamine)-DTPA-Gd as a blood pool MRI contrast agent.Multifunctional synthetic poly(L-glutamic acid)-based cancer therapeutic and imaging agents.Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study.Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.Metal-containing and related polymers for biomedical applications.Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK.Polymeric materials for theranostic applications.HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance.Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence.Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers.Synthetic Poly(L-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy With Increased Retention in Tumor and Draining Lymph Nodes After Intratumoral Injection in a Mouse Model of Melanoma.Engineered Bacterially Expressed Polypeptides: Assembly into Polymer Particles with Tailored Degradation Profiles
P2860
Q24616197-4515777D-51CC-4EDF-A34F-9BB521A20099Q30459975-0EB4A94F-6F99-4C2D-B1CD-7EED60482CB8Q30596925-3C63AC6E-C71C-48D9-AC34-F073451594FEQ31118122-91A2EB49-B6E1-4D1A-BEA1-946CF1870C0AQ31138139-6A99C8C4-445C-4D6A-9757-EC51D2F63846Q33279714-2F2C1A3D-7E9D-41B1-BBE8-790BE98C5090Q33847006-6B63BF43-FDB5-4213-BE22-DA569FB7AD59Q33948973-925A62BD-9C60-4767-9C0F-F3525B20C432Q33976776-298E7DF9-D97C-4107-B59C-09254C7D665EQ34810321-A2E70916-C4BA-4A01-A3D4-FD791E2F6223Q35608648-7BAFC5F7-CF99-49AF-B15C-718F72B22382Q35973677-9621F4A4-9FB1-4835-975D-67B5B4D6B1B9Q36214907-C6BAA90F-A7E6-45E0-A8E5-FC7BD58952CCQ36214917-C5364468-EEDA-4DBD-935A-DBA2757F47B2Q36690711-D96A0843-36F3-42B6-8DBD-BC89D41A8298Q37142843-DFAA2E6D-6802-488B-8921-C7C8177E2700Q37201391-630F49BB-92FB-4199-B236-49C02F5F4FA7Q37289392-5E9BDA22-75AA-47E4-A918-C09182B504ACQ38114360-48492853-DF2B-4BF6-9C3C-B0B27015B3DBQ39583685-ABE10CC3-AD9A-442B-8F2C-58BFDB401B19Q39710738-AE9B19E4-FCE3-4C2D-917C-5574503EA789Q39949731-826B464A-438C-4BAB-A97E-A0A39C9AB674Q49202561-395C0191-8260-4A8C-B15C-000177DF4058Q57645013-1DF8F97B-562F-4746-B0FF-4F81E332F3A1
P2860
Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Synthesis and characterization ...... degradable MRI contrast agent.
@en
type
label
Synthesis and characterization ...... degradable MRI contrast agent.
@en
prefLabel
Synthesis and characterization ...... degradable MRI contrast agent.
@en
P2093
P356
P1476
Synthesis and characterization ...... degradable MRI contrast agent.
@en
P2093
Chusilp Charnsangavej
E Edmund Kim
Juri G Gelovani
Qingping Wu
Roger E Price
Sidney Wallace
Xiaoxia Wen
P304
P356
10.1021/BC049910M
P577
2004-11-01T00:00:00Z